Atelectasis After Pulmonary Lobectomy: The Effect Of Air During One-Lung Ventilation (OLV) On Postoperative Atelectasis
NCT ID: NCT01289691
Last Updated: 2011-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2010-07-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary purpose of this study is to determine if the incidence of postoperative collapse (in the non-surgical lung) is decreased when using a mixture of air and oxygen compared to using only oxygen (which is our control measurement) during one-lung ventilation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pressure-Controlled vs Volume-Controlled Ventilation During One Lung Ventilation
NCT00975468
Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.
NCT05525312
Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation?
NCT00534690
The Effect of Two Airway Interventions, During One Lung Ventilation, on Blood Oxygen Content
NCT01495936
Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation
NCT03182062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is therefore to determine the impact of adding air to the inspired fraction of oxygen during (OLV) primarily on the incidence of postoperative atelectasis of the nonsurgical lung after lung resection using video assisted thoracic surgery and secondarily on intraoperative and postoperative oxygenation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Air/Oxygen Mixture
Patients in this group will be ventilated with a mixture of air and oxygen during one lung ventilation.
One Lung Ventilation
Patients in this group will be ventilated with a mixture of air and oxygen during one lung ventilation.
Oxygen
Patients in this group will be ventilated with only oxygen during one lung ventilation.
One Lung Ventilation
Patients in this group will be ventilated with only oxygen during one lung ventilation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
One Lung Ventilation
Patients in this group will be ventilated with a mixture of air and oxygen during one lung ventilation.
One Lung Ventilation
Patients in this group will be ventilated with only oxygen during one lung ventilation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Competent to give consent to enroll in study
* Booked for open thoracotomy procedure for lobectomy
* American Society of Anesthesiologists comorbidity score 1-4
Exclusion Criteria
* Pregnant women
* Inability to insert an arterial line
* Severe COPD (FEV1 \< .7% predicted, or FEV1/FVC \< 0.70)
* Presence of other significant pulmonary impairment (PaO2 on room air 50 mmHg, PaCO2 \> 50 mmHg or known pulmonary HTN mean PAP \> 25 mmHg)
* Presence of significant cardiovascular disease (+MIBI that is non-revascularized, CCS ≥ 3 angina, NYHA ≥ 3 CHF, EF (by angiography or echocardiogram \< 40%)
* Chronic renal failure (serum Cr \> 200)
* Altered liver function
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
London Health Sciences Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neal Badner, MD, FRCP(C)
Role: PRINCIPAL_INVESTIGATOR
London Health Science Centre, University Of Western Ontario
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Victoria Hospital
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Rothen HU, Sporre B, Engberg G, Wegenius G, Hogman M, Hedenstierna G. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology. 1995 Apr;82(4):832-42. doi: 10.1097/00000542-199504000-00004.
Schwarzkopf K, Klein U, Schreiber T, Preussetaler NP, Bloos F, Helfritsch H, Sauer F, Karzai W. Oxygenation during one-lung ventilation: the effects of inhaled nitric oxide and increasing levels of inspired fraction of oxygen. Anesth Analg. 2001 Apr;92(4):842-7. doi: 10.1097/00000539-200104000-00009.
Rothen HU, Sporre B, Engberg G, Wegenius G, Reber A, Hedenstierna G. Prevention of atelectasis during general anaesthesia. Lancet. 1995 Jun 3;345(8962):1387-91. doi: 10.1016/s0140-6736(95)92595-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LHSC2010AAPL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.